Healthcare provider profile · identity verified

Erhard J Bell, MD

Family Practice · INDIANAPOLIS, IN · NPI 1548242522

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	495	138
Amlodipine Besylate	Amlodipine Besylate	329	99
Alprazolam	Alprazolam	325	47
Lisinopril	Lisinopril	278	80
Omeprazole	Omeprazole	268	80
Levothyroxine Sodium	Levothyroxine Sodium	215	58
Prednisone	Prednisone	214	136
Gabapentin	Gabapentin	197	61
Losartan Potassium	Losartan Potassium	166	51
Tamsulosin Hcl	Tamsulosin Hcl	165	50
Tramadol Hcl	Tramadol Hcl	162	31
Sertraline Hcl	Sertraline Hcl	149	45
Pantoprazole Sodium	Pantoprazole Sodium	147	45
Metoprolol Succinate	Metoprolol Succinate	146	47
Tizanidine Hcl	Tizanidine Hcl	139	39
Albuterol Sulfate Hfa	Albuterol Sulfate	138	45
Metformin Hcl	Metformin Hcl	136	41
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	124	37
Simvastatin	Simvastatin	122	36
Duloxetine Hcl	Duloxetine Hcl	118	33
Zolpidem Tartrate	Zolpidem Tartrate	104	19
Allopurinol	Allopurinol	98	30
Rosuvastatin Calcium	Rosuvastatin Calcium	95	28
Hydrochlorothiazide	Hydrochlorothiazide	92	29
Meloxicam	Meloxicam	92	27
Naproxen	Naproxen	89	47
Doxycycline Hyclate	Doxycycline Hyclate	87	68
Alendronate Sodium	Alendronate Sodium	85	23
Metoprolol Tartrate	Metoprolol Tartrate	76	24
Fluticasone Propionate	Fluticasone Propionate	73	23
Synthroid	Levothyroxine Sodium	73	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	70	16
Escitalopram Oxalate	Escitalopram Oxalate	68	23
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	68	25
Trazodone Hcl	Trazodone Hcl	67	24
Mirtazapine	Mirtazapine	63	22
Ibuprofen	Ibuprofen	59	13
Clonazepam	Clonazepam	58	13
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	57	suppressed
Bupropion Xl	Bupropion Hcl	56	16
Spironolactone	Spironolactone	56	18
Carvedilol	Carvedilol	55	15
Montelukast Sodium	Montelukast Sodium	55	19
Pravastatin Sodium	Pravastatin Sodium	54	17
Topiramate	Topiramate	53	15
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	52	41
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	52	17
Diazepam	Diazepam	49	15
Atenolol	Atenolol	47	14
Citalopram Hbr	Citalopram Hydrobromide	45	12
Furosemide	Furosemide	45	18
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	44	12
Celecoxib	Celecoxib	42	15
Metformin Hcl Er	Metformin Hcl	42	14
Hydroxyzine Pamoate	Hydroxyzine Pamoate	41	14
Glimepiride	Glimepiride	40	14
Pregabalin	Pregabalin	38	11
Valsartan	Valsartan	38	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	37	12
Venlafaxine Hcl Er	Venlafaxine Hcl	37	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	36	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	36	suppressed
Clopidogrel	Clopidogrel Bisulfate	35	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	35	12
Ezetimibe	Ezetimibe	34	11
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	33	27
Ondansetron Hcl	Ondansetron Hcl	33	15
Esomeprazole Magnesium	Esomeprazole Magnesium	32	12
Famotidine	Famotidine	32	12
Breo Ellipta	Fluticasone/Vilanterol	30	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	30	11
Finasteride	Finasteride	28	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	28	suppressed
Baclofen	Baclofen	25	suppressed
Ondansetron Odt	Ondansetron	25	suppressed
Paroxetine Hcl	Paroxetine Hcl	25	suppressed
Cephalexin	Cephalexin	24	17
Etodolac	Etodolac	24	suppressed
Fenofibrate	Fenofibrate	24	suppressed
Levofloxacin	Levofloxacin	24	23
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	24	suppressed
Diclofenac Sodium	Diclofenac Sodium	23	suppressed
Acyclovir	Acyclovir	22	suppressed
Nabumetone	Nabumetone	22	suppressed
Telmisartan	Telmisartan	22	suppressed
Clobetasol Propionate	Clobetasol Propionate	21	suppressed
Lorazepam	Lorazepam	21	suppressed
Promethazine Hcl	Promethazine Hcl	20	suppressed
Benazepril Hcl	Benazepril Hcl	19	suppressed
Buspirone Hcl	Buspirone Hcl	19	suppressed
Raloxifene Hcl	Raloxifene Hcl	19	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	18	suppressed
Estradiol	Estradiol	18	suppressed
Propranolol Hcl Er	Propranolol Hcl	18	suppressed
Azelastine Hcl	Azelastine Hcl	17	suppressed
Prazosin Hcl	Prazosin Hcl	17	suppressed
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	suppressed
Rizatriptan	Rizatriptan Benzoate	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	14
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	15	suppressed
Eliquis	Apixaban	15	suppressed
Ketoconazole	Ketoconazole	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	15	14
Pilocarpine Hcl	Pilocarpine Hcl	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	14	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	14	suppressed
Potassium Chloride	Potassium Chloride	14	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Ramipril	Ramipril	14	suppressed
Cefuroxime	Cefuroxime Axetil	13	12
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Fluconazole	Fluconazole	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Methocarbamol	Methocarbamol	13	suppressed
Nebivolol Hcl	Nebivolol Hcl	13	suppressed
Temazepam	Temazepam	13	suppressed
Torsemide	Torsemide	13	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	12	suppressed
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	12	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Glipizide Er	Glipizide	11	suppressed
Klor-Con M10	Potassium Chloride	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed
Tobramycin	Tobramycin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error